Hospital at Home for Elderly Acute Ill Patients
Recruiting now · Not applicable
Conditions studied: Cystitis, Erysipelas, Pneumonia
In brief
Many elderly patients with uncomplicated treatment courses are admitted unnecessarily, which is a burden for the patient and society. Studies show that Hospital at Home (HaH) treatment is an alternative to hospitalization. The patient's risk of delirium, infection and loss of function is reduced when the patient avoids the hospital stay. HaH treatment is expected to be more cost-effective, improve patients' functional abilities and patients' satisfaction. Three municipalities, general practitioners, pre-hospital service and an emergency department (ED) in Central Denmark Region have organized the first HaH treatment model across disciplines and sectors. Specialists in the ED and the municipal acute teams provide HaH treatment for elderly acute ill patients. However, the model has not yet been evaluated. The aim of this study is to optimize the HaH treatment model for elderly acute ill patients. The objective is to increase patient satisfaction and optimize the use of resources in healthcare by avoiding unnecessary hospitalizations that impair and prolong treatment. This study is an open label randomized controlled trial (RCT) with a 1:2 allocation ratio of acute hospital admission versus HaH. During a pilot period, we tested and adapted the patient pathway of HaH to the practical reality, before we start the randomization for the RCT study. We will investigate the clinical effects and health economic consequences of HaH treatment compared with standard hospital treatment.
Key facts
- Study ID
- NCT05360914
- Run by
- Defactum, Central Denmark Region
- People needed
- 849
- Starts
- 2022-06-01
- Expected to finish
- 2027-08-01
- Last updated by the study team
- 2024-08-09
Who can join
Age: 65 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- The patient should be aged 65 and over
- Diagnosed with a stable acute medical conditions e.g. cystitis, erysipelas, pneumonia
- The patient should be living in their own home or a nursing home before entering the study
- The patient should be residing in one of the three municipalities (Viborg, Skive and Silkeborg)
- The patient must have been seen by the GP or the pre-hospital service in the case of disease in question
- The patient should speak and understand Danish.
- The patient should give informed consent to participate in the study.
You may not qualify if…
- The patient is unable to give written consent
- The capacity of the municipal acut team care was fully utilised.
Where it is running
- Silkeborg municipality — Silkeborg, Denmark (enrolling)
- Skive municipality — Skive, Denmark (enrolling)
- Viborg municipality — Viborg, Denmark (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.